IL-7:免疫细胞治疗的潜在下一代佐剂 IL-7: a potential next-generation adjuvant for immune cell therapies. PubMed 2026/01/02 发表Front ImmunolQ1 · IF 7(JCR 2025) 人群:儿童人群:成人技术:CAR-T膀胱癌多发性骨髓瘤地区:美国
ROR2 特异性 CAR-T 细胞对血液肿瘤和实体瘤有效且在小鼠中耐受良好 ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice. PubMed 2025/10/06 发表Cell Rep MedQ1 · IF 14(JCR 2025) 技术:CAR-T甲状腺癌多发性骨髓瘤膀胱癌地区:欧洲